Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

Abstract Introduction Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in a search for more effective treatment options. The...

Full description

Bibliographic Details
Main Authors: Yamuna Devi Bakthavatchalam, Ravikar Ralph, Balaji Veeraraghavan, Priyanka Babu, Elakkiya Munusamy
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-11-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40121-018-0224-z